Ingersoll-Rand Inc’s recent filing unveils that its Officer Schiesl Andrew R acquired Company’s shares for reported $1.15 million on Feb 18 ’25. In the deal valued at $87.05 per share,13,228 shares were bought.
Then, Scheske Michael J sold 2,531 shares, generating $246,621 in total proceeds. Upon selling the shares at $97.44, the VP, Chief Accounting Officer now owns 11,910 shares.
Before that, Schiesl Andrew R sold 24,234 shares. Ingersoll-Rand Inc shares valued at $2,304,241 were divested by the insider at a price of $95.08 per share. As a result of the transaction, Schiesl Andrew R now holds 30,846 shares, worth roughly $2.68 million.
Stifel downgraded its Ingersoll-Rand Inc [IR] rating to a Hold from a a Buy in a research note published on November 18, 2024; the price target was decreased to $107 from $112. Morgan Stanley began covering IR with “an Equal-weight” recommendation on September 06, 2024.
Price Performance Review of IR
On Tuesday, Ingersoll-Rand Inc [NYSE:IR] saw its stock jump 1.20% to $86.75. Over the last five days, the stock has lost -5.89%. Ingersoll-Rand Inc shares have fallen nearly -4.10% since the year began. Nevertheless, the stocks have risen 0.30% over the past one year. While a 52-week high of $106.03 was reached on 01/31/25, a 52-week low of $83.72 was recorded on 02/14/25. SMA at 50 days reached $93.40, while 200 days put it at $94.58.
Levels Of Support And Resistance For IR Stock
The 24-hour chart illustrates a support level at 85.93, which if violated will result in even more drops to 85.10. On the upside, there is a resistance level at 87.34. A further resistance level may holdings at 87.92. The Relative Strength Index (RSI) on the 14-day chart is 35.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.52%. Stochastics %K at 4.80% indicates the stock is a buying.
The most recent change occurred on March 12, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”a Neutral”‘ rating along with a $92 price target.
